EHA 2023 | Addressing inequalities in access to CAR-T therapy
Matthew Frank
• 10 Jun 2023
Matthew Frank, MD, PhD, Stanford University, Stanford, CA, comments on the importance of enhancing access to novel therapies including CAR-T therapy, highlighting the need to improve access to clinical trials and to partner with community groups who advocate for minority groups. This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
